Notably, other results for IL-12B (MR Egger: OR = 0.845, 95% CI: 0.755–0.945, P = .008; weighted median: OR = 0.884, 95% CI: 0.810–0.965, P = .006; weighted mode: OR = 0.887, 95% CI: 0.811–0.969, P = .015;) also indicated a negative association with the risk of prostatitis. Here, IL12B is linked to male reproductive organ cancer.